From Radiopharmaceuticals to Proton Beams: The Future of Precision Medicine

PCI is hosting our Innovation @ Penn program in San Francisco on January 11, 2027, at 3 pm. This event, held concurrently during the annual JP Morgan Healthcare Conference, is an excellent opportunity to learn about emerging areas of innovation and opportunities for partnership with Penn. The program attracts professionals from across the life science industry, the investor community, and other stakeholders, and provides a platform for in-depth discussions about emerging healthcare technologies and their practical applications.

PCI is honored to have an outstanding group of participants in this year's panel, including Scott Claunch, RPH, President of TerraPower Isotopes, Robert Mach, PhD, The Britton Chance Professor of Radiology, Mark Sellmyer, MD, PhD, The Gerd Muehllehner Associate Professor of Radiology, and Neha Vapiwala, MD, FACR, FASTRO, FASCO, The Eli Glatstein Professor in Radiation Oncology, all of Penn Medicine. Kevin Mahoney, DBA, MBA, Chief Executive Officer, University of Pennsylvania Health System, will provide opening remarks.